CORDIS · 101159555 · HORIZON

ASCLEPIUS Advancing scientific collaboration in phage therapy for treating Pseudomonas aeruginosa and Staphylococcus aureus

Coordinator: GIORGI ELIAVA INSTITUTE OF BACTERIOPHAGY, MICROBIOLOGY AND VIROLOGY (GE)

ASCLEPIUS’s overall aim is to boost the scientific excellence and innovation capacity of Giorgi Eliava Institute of Bacteriophagy, Microbiology and Virology (Eliava) and its high-quality Twinning partners - l’Institut national de recherche pour l’agriculture, l’alimentation et l’environnement, Universidade do Minho and Intelligentsia Consultants Sarl – to expand their insights in phage therapy for treating Pseudomonas aeruginosa and Staphylococcus aureus. To achieve this aim, ASCLEPIUS will implement a research and innovation strategy over three years based upon five objectives:Objective 1: C…

EU contribution
€1.5M
Total cost
€0
Period
2024-10-01 → 2027-09-30
Framework
Horizon Europe (2021–2027)
Funding scheme
HORIZON-CSA
Call
HORIZON-WIDERA-2023-ACCESS-02
Status
SIGNED

About Horizon Europe (2021–2027)

Horizon Europe is the EU's current research and innovation programme, covering 2021 to 2027 with a budget of roughly €95.5 billion. Its three pillars are Excellent Science (frontier research and mobility), Global Challenges and European Industrial Competitiveness (mission-driven collaborative projects in health, climate, digital, security and food) and Innovative Europe (the EIC and EIT). It also funds five EU Missions targeting cancer, climate adaptation, smart cities, oceans and soils.

0 EU contribution: €1.5M awarded to the consortium. The project runs over approximately 3 years from 2024-10-01 to 2027-09-30.

Full record on CORDIS — partners, deliverables, publications, news.

Open on cordis.europa.eu → Grant DOI ↗

Frequently asked questions

Who funds this research project?
This project is funded by the European Union through the Horizon Europe (2021–2027) programme, under the HORIZON-CSA funding scheme.
What is the EU contribution?
The European Commission contributes €1.5M.
Which EU programme funds it?
The project is funded under Horizon Europe (2021–2027), call HORIZON-WIDERA-2023-ACCESS-02.
Who coordinates the project?
The project is coordinated by GIORGI ELIAVA INSTITUTE OF BACTERIOPHAGY, MICROBIOLOGY AND VIROLOGY (GE).
What is the project timeline?
The project runs from 2024-10-01 to 2027-09-30 — approximately 3 years.
Where can I find the full project record?
The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 101159555.